Manage supportive care for your
cancer patient’s drug therapy
based on their genetics

PGxOnco™ is a genetic test that can help predict
how a patient will respond to drug therapy

Sample Report
Sample Report
Information Sheet
Information Sheet
PGxOnco_logo_web_small-e1534859993640 PGxOnco

Improve supportive care from diagnosis to outcome

PGxOnco_icon2_small PGxOnco

Precise prescribing of
pain management and
mental health
medications

PGxOnco_icon1_small PGxOnco

Actionable
reports to
implement your
treatment plan

PGxOnco_icon3_small PGxOnco

More effective
toxicity
management

PGxOnco_icon4_small PGxOnco

Cost savings from
reduced supportive
care issues

PGxOnco_logo_web_small-e1534859993640 PGxOnco
Improve supportive care from diagnosis to outcome
PGxOnco_icon2_small PGxOnco
Precise prescribing of
pain management and
mental health
medications
PGxOnco_icon1_small PGxOnco
Actionable
reports to
implement your
treatment plan
PGxOnco_icon3_small PGxOnco
More effective
toxicity
management
PGxOnco_icon4_small PGxOnco
Cost savings from
reduced supportive
care issues

Supportive Care

Addressing supportive care issues can require significant effort. With PGxOncoTM testing,
physicians can be well-prepared in managing many facets of patient care.

Pain_Management_icon_small PGxOnco

Pain Management Drugs

PGxOnco™ testing can guide optimum treatment of cancer-related pain for both current patients and survivors.

Depressive_icon_small PGxOnco

Anti-depression Drugs

When anxiety, fear or depression emerge, medication may be indicated. PGxOnco™ can enable faster relief by reducing trial-and-error prescribing and dosage titration.

CINV_icon_small PGxOnco

CINV

Chemotherapy-induced nausea and vomiting are major concerns associated with cancer treatment. PGxOnco™ testing can help reduce these side effects and improve quality of life by optimizing drug therapy.

Supportive Care

Addressing supportive care issues can require significant effort. With PGxOncoTM testing,
physicians can be well-prepared in managing many facets of patient care.

Pain_Management_icon_small PGxOnco

Pain Management Drugs

PGxOnco™ testing can guide
optimum treatment of
cancer-related pain for both
current patients and survivors.

Depressive_icon_small PGxOnco

Anti-depression Drugs

When anxiety, fear or depression
emerge, medication may be
indicated. PGxOnco™ can enable
faster relief by reducing trial-and-error
prescribing and dosage titration.

CINV_icon_small PGxOnco

CINV

Chemotherapy-induced nausea and vomiting are major concerns associated with cancer treatment. PGxOnco™ testing can help reduce these side effects and improve quality of life by optimizing drug therapy.

additional_areas_small PGxOnco

Additional Therapeutic Areas

Recommendations also include therapeutic areas not
traditionally associated with cancer treatment to assist the
oncologist who steps in as the primary care physician.
One such area is cardiology.

additional_areas_small PGxOnco

Additional Therapeutic Areas

Recommendations also include therapeutic areas not traditionally associated with cancer treatment to assist the oncologist who steps in as the primary care physician. One such area is cardiology.

Chemotherapeutic Response

Efficacy and tolerance of chemotherapeutic drugs varies widely. A key contributing factor is genetics. For example, 5-FU, a commonly used chemotherapeutic is often poorly metabolized by patients with certain DPYD variants.

This puts them at significant risk of:
Cardiovascular: myocardial ischemia, angina
Gastrointestinal: gastrointestinal ulceration, bleeding, and intensive diarrhea
Hematology: anemia, thrombocytopenia
Psychiatric: disorientation, confusion, depression
In severe cases, accelerated death

5fu_graphic_PGxOnco PGxOnco
Practice_efficiencies_icon-e1534775690446 PGxOnco

Practice Efficiencies

Free up resources by reducing:

  • Sequential therapy changes
  • Better manage immunocompromised patients
  • Efforts spent on treating cancer-related infections
  • Time addressing drug toxicity
Cost_containment_icon PGxOnco

Cost Containment

Improve patient outcomes by:

  • Providing proper drug dosages
  • Guiding alternative drug selection
  • Reducing prolonged and unnecessary hospital stays
  • Lowering cost of infectious disease drugs

Clear, Color-Coded Results

Results are delivered in an easy to manage report, providing the relevant
information to make more informed treatment decisions

PGxOnco™ complements Admera Health’s suite of molecular diagnostics:

oncogxselect PGxOnco

Solid tumor profiling for
targeted therapy selection
following established guidelines

Learn more
oncogxone PGxOnco

Comprehensive solid tumor
profiling for targeted therapy
selection

Learn more
liquidgx PGxOnco

Liquid biopsy allowing
for monitoring of targeted
therapy treatment

Learn more